CoChat

Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies

Hanlon, Peter, Jani, Bhautesh D., Nicholl, Barbara, Lewsey, Jim, McAllister, David A., Mair, Frances S. · 2022 · PLOS Medicine
Cited by 73

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background: Cohorts such as UK Biobank are increasingly used to study multimorbidity; however, there are concerns that lack of representativeness may lead to biased results. This study aims to compare associations between multimorbidity and adverse health outcomes in UK Biobank and a nationally representative sample. Methods and findings: These are observational analyses of cohorts identified from linked routine healthcare data from UK Biobank participants (n = 211,597 from England, Scotland, and Wales with linked primary care data, age 40 to 70, mean age 56.5 years, 54.6% women, baseline assessment 2006 to 2010) and from the Secure Anonymised Information Linkage (SAIL) databank (n = 852,055 from Wales, age 40 to 70, mean age 54.2, 50.0% women, baseline January 2011). Multimorbidity (n = 40 long-term conditions [LTCs]) was identified from primary care Read codes and quantified using a simple count and a weighted score. Individual LTCs and LTC combinations were also assessed. Associations with all-cause mortality, unscheduled hospitalisation, and major adverse cardiovascular events (MACEs) were assessed using Weibull or negative binomial models adjusted for age, sex, and socioeconomic status, over 7.5 years follow-up for both datasets. Multimorbidity was less common in UK Biobank than SAIL (26.9% and 33.0% with ≥2 LTCs in UK Biobank and SAIL, respectively). This difference was attenuated, but persisted, after standardising by age, sex, and socioeconomic status. The association between increasing multimorbidity count and mortality, hospitalisation, and MACE was similar between both datasets at LTC counts of ≤3; however, above this level, UK Biobank underestimated the risk associated with multimorbidity (e.g., mortality hazard ratio for 2 LTCs 1.62 (95% confidence interval 1.57 to 1.68) in SAIL and 1.51 (1.43 to 1.59) in UK Biobank, hazard ratio for 5 LTCs was 3.46 (3.31 to 3.61) in SAIL and 2.88 (2.63 to 3.15) in UK Biobank). Absolute risk of mortality, hospitalisation, and MACE, at all levels of multimorbidity, was lower in UK Biobank than SAIL (adjusting for age, sex, and socioeconomic status). Both cohorts produced similar hazard ratios for some LTCs (e.g., hypertension and coronary heart disease), but UK Biobank underestimated the risk for others (e.g., alcohol-related disorders or mental health conditions). Hazard ratios for some LTC combinations were similar between the cohorts (e.g., cardiovascular conditions); however, UK Biobank underestimated the risk for combinations including other conditions (e.g., mental health conditions). The main limitations are that SAIL databank represents only part of the UK (Wales only) and that in both cohorts we lacked data on severity of the LTCs included. Conclusions: In this study, we observed that UK Biobank accurately estimates relative risk of mortality, unscheduled hospitalisation, and MACE associated with LTC counts ≤3. However, for counts ≥4, and for some LTC combinations, estimates of magnitude of association from UK Biobank are likely to be conservative. Researchers should be mindful of these limitations of UK Biobank when conducting and interpreting analyses of multimorbidity. Nonetheless, the richness of data available in UK Biobank does offers opportunities to better understand multimorbidity, particularly where complementary data sources less susceptible to selection bias can be used to inform and qualify analyses of UK Biobank.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1003931

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 24

  1. CJ Whitty, 2020, Rising to the challenge of multimorbidity, BMJ, 368
  2. H Nguyen, 2019, Prevalence of multimorbidity in community settings: A systematic review and meta-analysis of observational studies, J Comorb, 9, 10.1177/2235042X19870934 · DOI · Paper page
  3. SH van Oostrom, 2016, Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: data from general practices and health surveys, PLoS ONE, 11, e0160264, 10.1371/journal.pone.0160264 · DOI · Paper page
  4. BD Jani, 2019, Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort, BMC Med, 17, 74, 10.1186/s12916-019-1305-x · DOI · Paper page
  5. RA Payne, 2020, Development and validation of the Cambridge Multimorbidity Score, CMAJ, 192, E107, 10.1503/cmaj.190757 · DOI · Paper page
  6. DL Vetrano, 2020, Twelve-year clinical trajectories of multimorbidity in a population of older adults, Nat Commun, 11, 1, 10.1038/s41467-020-16780-x · DOI · Paper page
  7. Y Zhu, 2020, Characteristics, service use and mortality of clusters of multimorbid patients in England: a population-based study, BMC Med, 18, 1
  8. DT Zemedikun, 2018, editors. Patterns of multimorbidity in middle-aged and older adults: an analysis of the UK Biobank data, Mayo Clin Proc, 93, 857, 10.1016/j.mayocp.2018.02.012 · DOI · Paper page
  9. P Hanlon, 2018, Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants, Lancet Public Health, 3, e323, 10.1016/S2468-2667(18)30091-4 · DOI · Paper page
  10. RM Dodds, 2020, Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants, J Cachexia Sarcopenia Muscle, 11, 62, 10.1002/jcsm.12503 · DOI · Paper page
  11. E Di Angelantonio, 2015, Association of cardiometabolic multimorbidity with mortality, JAMA, 314, 52, 10.1001/jama.2015.7008 · DOI · Paper page
  12. JI Chiang, 2020, Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts, PLoS Med, 17, e1003094, 10.1371/journal.pmed.1003094 · DOI
  13. P Hanlon, 2021, An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes, Commun Med (London), 1, 1
  14. MK Sullivan, 2021, Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings, BMC Med, 19, 278, 10.1186/s12916-021-02147-6 · DOI
  15. TA Manolio, 2010, Enhancing the Feasibility of Large Cohort Studies, JAMA, 304, 2290, 10.1001/jama.2010.1686 · DOI · Paper page
  16. GJ Griffith, 2020, Collider bias undermines our understanding of COVID-19 disease risk and severity, Nat Commun, 11, 5749, 10.1038/s41467-020-19478-2 · DOI · Paper page
  17. C Infante-Rivard, 2018, Reflection on modern methods: selection bias—a review of recent developments, Int J Epidemiol, 47, 1714, 10.1093/ije/dyy138 · DOI
  18. KH Jones, 2019, A profile of the Sail Databank on the UK secure research platform, Int J Popul Data Sci, 4
  19. C Schnier, 2020, The secure Anonymised information linkage databank dementia e-cohort (SAIL-DeC), Int J Popul Data Sci, 5
  20. P Hanlon, 2019, Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis, BMC Med, 17, 201, 10.1186/s12916-019-1427-1 · DOI
  21. P Townsend, 1988, Health and deprivation: inequality and the North: Routledge
  22. F Yang, 2016, Socioeconomic status in relation to Parkinson’s disease risk and mortality: A population-based prospective study, Medicine, 95, 10.1097/MD.0000000000004337 · DOI
  23. P Hanlon, 2020, Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions, BMC Med, 18, 1, 10.1186/s12916-020-01752-1 · DOI
  24. P Hanlon, 2020, Association between childhood maltreatment and the prevalence and complexity of multimorbidity: A cross-sectional analysis of 157,357 UK Biobank participants, J Comorb, 10, 10.1177/2235042X10944344 · DOI

Metadata

Authors
Hanlon, P., Jani, B. D., Nicholl, B., Lewsey, J., McAllister, D. A., & Mair, F. S.
Venue
PLOS Medicine
Published
2022-03-07
Volume
19
Issue
3
Pages
e1003931
ISSN
1549-1676
Cited by
73
References
9
Language
en
Funders
  • Medical Research Council (MR/S021949/1)
  • Wellcome Trust (201492/Z/16/Z)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies. https://app.cochat.ai/papers/10.1371/journal.pmed.1003931
The paper
Hanlon, P., Jani, B. D., Nicholl, B., Lewsey, J., McAllister, D. A., & Mair, F. S. (2022). Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1003931

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.